Our Faculty

Scientists collaberate while working at a computer

With 130+ physician and research faculty members, our division is one of the largest in the country. Our faculty members participate in every facet of cancer prevention, patient care, survivorship, mentorship, and research on cancer and related diseases.

This is unpublished

Physician & Research Faculty Profiles 

 

Notable Faculty achievements

  • Faculty have been elected by their peers to lead the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the American Society for Transplantation and Cellular Therapy, the World Marrow Donor Association, the American Society for Blood and Marrow Transplantation, and the National Cancer Institute’s Leukemia and Lymphoma Steering Committees.
  • Many faculty members have been chosen to determine standardized cancer care guidelines through the National Comprehensive Cancer Network.
  • Faculty have been editors-in-chief of major textbooks and professional journals.
  • Faculty published more than 400 peer-reviewed journal articles in 2019.
  • Our faculty continue to be chosen by their peers for Seattle Magazine’s Best Doctors list. In 2022 twelve faculty members were honored.
  • Sixteen faculty members hold endowed chairs. 
  • Our division was founded by Dr. E. Donnall Thomas, who received the Nobel Prize for his work in developing bone marrow transplantation.

Faculty news

February 20, 2025
American Society for Transplantation and Cellular Therapy awards
Congratulations to Drs. Mary Flowers and Erik Kimble who received 2025 ASTCT awards.
February 10, 2025
Novel regimen greatly reduced chronic GVHD in phase 2 study
A novel drug regimen has shown great promise in preventing moderate to severe cGVHD after transplant in people who received nonmyeloablative or reduced-intensity conditioning to treat a blood cancer.
January 31, 2025
Sara Hurvitz receives Smith Family Endowed Chair in Women’s Health
This new endowed chair will provide an enduring source of flexible funding to help fuel efforts to improve survivorship and quality of life for women with cancer.